Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • ANTITRUST—N.D. Cal.: Coretronic fails to plead Sherman Act claim against Maxell in connection with projector patent
    • ANTITRUST NEWS: FTC, states move for contempt against Shkreli for violating ban
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ANTITRUST NEWS: Warren urges regulators to closely scrutinize food, grocery industry mergers
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ANTITRUST—R.I. Super. Ct.: URI football players denied injunction in antitrust challenge to NCAA eligibility rules
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FRANCHISING & DISTRIBUTION—E.D. Wis.: ‘Right to control’ test might support Applebee’s franchisor liability for alleged law enforcement incident
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FRANCHISING & DISTRIBUTION—S.D. Ohio: Court mostly denies dismissal motions by hotels in eight related alleged sex-trafficking victim cases
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PRIVACY NEWS: Google’s plans for airline’s employee data prompts privacy warning from 121 lawmakers
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Antitrust Law Daily Wrap Up, ANTITRUST NEWS: FTC, states move for contempt against Shkreli for violating ban, (Oct 13, 2026)

    By Peter Reap, J.D., LL.M.

    Shkreli, who gained notoriety as the “Pharma Bro” for his involvement with companies that sharply increased the prices of drugs, is flagrantly violating his pharmaceutical industry ban, the government contends.

    The FTC announced that it ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use